Literature DB >> 16403852

Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon.

Clint A Rosenfeld1, Lester G Sultatos.   

Abstract

For decades the interaction of the anticholinesterase organophosphorus compounds with acetylcholinesterase has been characterized as a straightforward phosphylation of the active site serine (Ser-203) which can be described kinetically by the inhibitory rate constant k(i). However, more recently certain kinetic complexities in the inhibition of acetylcholinesterase by organophosphates such as paraoxon (O,O-diethyl O-(p-nitrophenyl) phosphate) and chlorpyrifos oxon (O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) phosphate) have raised questions regarding the adequacy of the kinetic scheme on which k(i) is based. The present article documents conditions in which the inhibitory capacity of paraoxon towards human recombinant acetylcholinesterase appears to change as a function of oxon concentration (as evidenced by a changing k(i)), with the inhibitory capacity of individual oxon molecules increasing at lower oxon concentrations. Optimization of a computer model based on an Ordered Uni Bi kinetic mechanism for phosphylation of acetylcholinesterse determined k(1) to be 0.5 nM(-1)h(-1), and k(-1) to be 169.5 h(-1). These values were used in a comparison of the Ordered Uni Bi model versus a k(i) model in order to assess the capacity of k(i) to describe accurately the inhibition of acetylcholinesterase by paraoxon. Interestingly, the k(i) model was accurate only at equilibrium (or near equilibrium), and when the inhibitor concentration was well below its K(d) (pseudo first order conditions). Comparisons of the Ordered Uni Bi and k(i) models demonstrate the changing k(i) as a function of inhibitor concentrations is not an artifact resulting from inappropriate inhibitor concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16403852     DOI: 10.1093/toxsci/kfj094

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  13 in total

1.  Chlorpyrifos-oxon disrupts zebrafish axonal growth and motor behavior.

Authors:  Dongren Yang; Holly Lauridsen; Kalmia Buels; Lai-Har Chi; Jane La Du; Donald A Bruun; James R Olson; Robert L Tanguay; Pamela J Lein
Journal:  Toxicol Sci       Date:  2011-02-23       Impact factor: 4.849

2.  Synthesis and anti-acetylcholinesterase properties of novel β- and γ-substituted alkoxy organophosphonates.

Authors:  S Kaleem Ahmed; Yamina Belabassi; Lakshmi Sankaranarayanan; Chih-Kai Chao; John M Gerdes; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

3.  Interpretation of the mechanism of acetylcholinesterase inhibition ability by organophosphorus compounds through a new conformational descriptor. an experimental and theoretical study.

Authors:  Guido Mastrantonio; Hans-Georg Mack; Carlos Omar Della Védova
Journal:  J Mol Model       Date:  2008-06-26       Impact factor: 1.810

4.  An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon.

Authors:  Josephine Shenouda; Paula Green; Lester Sultatos
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-19       Impact factor: 4.219

5.  Chlorpyrifos and chlorpyrifos-oxon inhibit axonal growth by interfering with the morphogenic activity of acetylcholinesterase.

Authors:  Dongren Yang; Angela Howard; Donald Bruun; Mispa Ajua-Alemanj; Cecile Pickart; Pamela J Lein
Journal:  Toxicol Appl Pharmacol       Date:  2007-11-17       Impact factor: 4.219

6.  Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase.

Authors:  R Kaushik; Clint A Rosenfeld; L G Sultatos
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-24       Impact factor: 4.219

7.  Poly(2-oxazoline)s with a 2,2'-Iminodiacetate End Group Inhibit and Stabilize Laccase.

Authors:  Montasser Hijazi; Esra Türkmen; Joerg C Tiller
Journal:  Chembiochem       Date:  2019-12-13       Impact factor: 3.164

8.  Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases.

Authors:  Dengfeng Dou; Jewn Giew Park; Sandeep Rana; Benjamin J Madden; Haobo Jiang; Yuan-Ping Pang
Journal:  Sci Rep       Date:  2013-01-15       Impact factor: 4.379

9.  The Targeted Pesticides as Acetylcholinesterase Inhibitors: Comprehensive Cross-Organism Molecular Modelling Studies Performed to Anticipate the Pharmacology of Harmfulness to Humans In Vitro.

Authors:  Milan Mladenović; Biljana B Arsić; Nevena Stanković; Nezrina Mihović; Rino Ragno; Andrew Regan; Jelena S Milićević; Tatjana M Trtić-Petrović; Ružica Micić
Journal:  Molecules       Date:  2018-08-30       Impact factor: 4.411

10.  Acetylcholinesterase Inhibition and Antioxidant Activity of N-trans-Caffeoyldopamine and N-trans-Feruloyldopamine.

Authors:  Muamer Dizdar; Danijela Vidic; Franc Požgan; Bogdan Štefane; Milka Maksimović
Journal:  Sci Pharm       Date:  2018-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.